149 related articles for article (PubMed ID: 28402962)
21. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
22. Application of Cancer Cell Reprogramming Technology to Human Cancer Research.
Pan XY; Tsai MH; Wuputra K; Ku CC; Lin WH; Lin YC; Kishikawa S; Noguchi M; Saito S; Lin CS; Yokoyama KK
Anticancer Res; 2017 Jul; 37(7):3367-3377. PubMed ID: 28668824
[TBL] [Abstract][Full Text] [Related]
23. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
[TBL] [Abstract][Full Text] [Related]
24. Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine.
Qiao Y; Agboola OS; Hu X; Wu Y; Lei L
Stem Cell Rev Rep; 2020 Dec; 16(6):1049-1061. PubMed ID: 32939647
[TBL] [Abstract][Full Text] [Related]
25. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
26. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
Iglesias-García O; Pelacho B; Prósper F
J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
[TBL] [Abstract][Full Text] [Related]
27. Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors.
Hwang Y; Broxmeyer HE; Lee MR
Curr Opin Hematol; 2017 Jul; 24(4):283-288. PubMed ID: 28383341
[TBL] [Abstract][Full Text] [Related]
28. Insensitivity of Human iPS Cells-Derived Mesenchymal Stem Cells to Interferon-γ-induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice.
Sun YQ; Zhang Y; Li X; Deng MX; Gao WX; Yao Y; Chiu SM; Liang X; Gao F; Chan CW; Tse HF; Shi J; Fu QL; Lian Q
Stem Cells; 2015 Dec; 33(12):3452-67. PubMed ID: 26175298
[TBL] [Abstract][Full Text] [Related]
29. Silencing of E6/E7 expression in cervical cancer stem-like cells.
Gu W; McMillan N; Yu C
Methods Mol Biol; 2015; 1249():173-82. PubMed ID: 25348305
[TBL] [Abstract][Full Text] [Related]
30. In vitro characterization of neurite extension using induced pluripotent stem cells derived from lissencephaly patients with TUBA1A missense mutations.
Bamba Y; Shofuda T; Kato M; Pooh RK; Tateishi Y; Takanashi J; Utsunomiya H; Sumida M; Kanematsu D; Suemizu H; Higuchi Y; Akamatsu W; Gallagher D; Miller FD; Yamasaki M; Kanemura Y; Okano H
Mol Brain; 2016 Jul; 9(1):70. PubMed ID: 27431206
[TBL] [Abstract][Full Text] [Related]
31. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effects of carboxymethyl-hexanoyl chitosan, cationic polyurethane-short branch PEI in miR122 gene delivery: accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved stem cell therapy in a hepatic failure model.
Chien Y; Chang YL; Li HY; Larsson M; Wu WW; Chien CS; Wang CY; Chu PY; Chen KH; Lo WL; Chiou SH; Lan YT; Huo TI; Lee SD; Huang PI
Acta Biomater; 2015 Feb; 13():228-44. PubMed ID: 25463491
[TBL] [Abstract][Full Text] [Related]
33. Structural Changes in N-Glycans on Induced Pluripotent Stem Cells Differentiating Toward Cardiomyocytes.
Kawamura T; Miyagawa S; Fukushima S; Kashiyama N; Kawamura A; Ito E; Saito A; Maeda A; Eguchi H; Toda K; Miyagawa S; Okuyama H; Sawa Y
Stem Cells Transl Med; 2015 Nov; 4(11):1258-64. PubMed ID: 26378261
[TBL] [Abstract][Full Text] [Related]
34. Genetic Correction of Induced Pluripotent Stem Cells From a Deaf Patient With MYO7A Mutation Results in Morphologic and Functional Recovery of the Derived Hair Cell-Like Cells.
Tang ZH; Chen JR; Zheng J; Shi HS; Ding J; Qian XD; Zhang C; Chen JL; Wang CC; Li L; Chen JZ; Yin SK; Huang TS; Chen P; Guan MX; Wang JF
Stem Cells Transl Med; 2016 May; 5(5):561-71. PubMed ID: 27013738
[TBL] [Abstract][Full Text] [Related]
35. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.
Liu K; Ji G; Mao J; Liu M; Wang L; Chen C; Liu L
Cell Reprogram; 2012 Dec; 14(6):505-13. PubMed ID: 23035653
[TBL] [Abstract][Full Text] [Related]
36. Limited Immunogenicity of Human Induced Pluripotent Stem Cell-Derived Cartilages.
Kimura T; Yamashita A; Ozono K; Tsumaki N
Tissue Eng Part A; 2016 Dec; 22(23-24):1367-1375. PubMed ID: 27762664
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
[TBL] [Abstract][Full Text] [Related]
38. Modeling of hematologic malignancies by iPS technology.
Arai S; Miyauchi M; Kurokawa M
Exp Hematol; 2015 Aug; 43(8):654-60. PubMed ID: 26135030
[TBL] [Abstract][Full Text] [Related]
39. Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth.
Olmez I; Shen W; McDonald H; Ozpolat B
J Cell Mol Med; 2015 Jun; 19(6):1262-72. PubMed ID: 25787115
[TBL] [Abstract][Full Text] [Related]
40. Interconversion of Cancer Cells and Induced Pluripotent Stem Cells.
Sarker DB; Xue Y; Mahmud F; Jocelyn JA; Sang QA
Cells; 2024 Jan; 13(2):. PubMed ID: 38247819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
